99 related articles for article (PubMed ID: 25573666)
21. 2G12-expressing B cell lines may aid in HIV carbohydrate vaccine design strategies.
Doores KJ; Huber M; Le KM; Wang SK; Doyle-Cooper C; Cooper A; Pantophlet R; Wong CH; Nemazee D; Burton DR
J Virol; 2013 Feb; 87(4):2234-41. PubMed ID: 23221565
[TBL] [Abstract][Full Text] [Related]
22. Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12.
Calarese DA; Lee HK; Huang CY; Best MD; Astronomo RD; Stanfield RL; Katinger H; Burton DR; Wong CH; Wilson IA
Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13372-7. PubMed ID: 16174734
[TBL] [Abstract][Full Text] [Related]
23. Reactivity-based one-pot synthesis of oligomannoses: defining antigens recognized by 2G12, a broadly neutralizing anti-HIV-1 antibody.
Lee HK; Scanlan CN; Huang CY; Chang AY; Calarese DA; Dwek RA; Rudd PM; Burton DR; Wilson IA; Wong CH
Angew Chem Int Ed Engl; 2004 Feb; 43(8):1000-3. PubMed ID: 14966891
[No Abstract] [Full Text] [Related]
24. Synthesis of high-mannose 1-thio glycans and their conjugation to protein.
Bailey JJ; Bundle DR
Org Biomol Chem; 2014 Apr; 12(14):2193-213. PubMed ID: 24549150
[TBL] [Abstract][Full Text] [Related]
25. HIV-1 envelope trimer has similar binding characteristics for carbohydrate-binding agents as monomeric gp120.
Hoorelbeke B; van Montfort T; Xue J; LiWang PJ; Tanaka H; Igarashi Y; Van Damme EJ; Sanders RW; Balzarini J
FEBS Lett; 2013 Apr; 587(7):860-6. PubMed ID: 23454641
[TBL] [Abstract][Full Text] [Related]
26. A nonself sugar mimic of the HIV glycan shield shows enhanced antigenicity.
Doores KJ; Fulton Z; Hong V; Patel MK; Scanlan CN; Wormald MR; Finn MG; Burton DR; Wilson IA; Davis BG
Proc Natl Acad Sci U S A; 2010 Oct; 107(40):17107-12. PubMed ID: 20852065
[TBL] [Abstract][Full Text] [Related]
27. Accessibility of the high-mannose glycans of glycoprotein gp120 from human immunodeficiency virus type 1 probed by in vitro interaction with mannose-binding lectins.
Astoul CH; Peumans WJ; Van Damme EJ; Roug
Biochem Biophys Res Commun; 2000 Aug; 274(2):455-60. PubMed ID: 10913359
[TBL] [Abstract][Full Text] [Related]
28. Resistance of HIV-1 to the broadly HIV-1-neutralizing, anti-carbohydrate antibody 2G12.
Huskens D; Van Laethem K; Vermeire K; Balzarini J; Schols D
Virology; 2007 Apr; 360(2):294-304. PubMed ID: 17123566
[TBL] [Abstract][Full Text] [Related]
29. High temperature SELMA: evolution of DNA-supported oligomannose clusters which are tightly recognized by HIV bnAb 2G12.
Temme JS; MacPherson IS; DeCourcey JF; Krauss IJ
J Am Chem Soc; 2014 Feb; 136(5):1726-9. PubMed ID: 24446826
[TBL] [Abstract][Full Text] [Related]
30. Polyepitope protein incorporated the HIV-1 mimotope recognized by monoclonal antibody 2G12.
Karpenko LI; Scherbakova NS; Chikaev AN; Tumanova OY; Lebedev LR; Shalamova LA; Pyankova OG; Ryzhikov AB; Ilyichev AA
Mol Immunol; 2012 Apr; 50(4):193-9. PubMed ID: 22341130
[TBL] [Abstract][Full Text] [Related]
31. A bacterial lipooligosaccharide that naturally mimics the epitope of the HIV-neutralizing antibody 2G12 as a template for vaccine design.
Clark BE; Auyeung K; Fregolino E; Parrilli M; Lanzetta R; De Castro C; Pantophlet R
Chem Biol; 2012 Feb; 19(2):254-63. PubMed ID: 22365608
[TBL] [Abstract][Full Text] [Related]
32. Gold nanoparticles capped with sulfate-ended ligands as anti-HIV agents.
Di Gianvincenzo P; Marradi M; Martínez-Avila OM; Bedoya LM; Alcamí J; Penadés S
Bioorg Med Chem Lett; 2010 May; 20(9):2718-21. PubMed ID: 20382017
[TBL] [Abstract][Full Text] [Related]
33. Large-Scale Synthesis of Man
Neralkar M; Xu B; Horiya S; Krauss IJ
ACS Infect Dis; 2022 Nov; 8(11):2232-2241. PubMed ID: 36278940
[TBL] [Abstract][Full Text] [Related]
34. Toward a carbohydrate-based HIV-1 vaccine: synthesis and immunological studies of oligomannose-containing glycoconjugates.
Ni J; Song H; Wang Y; Stamatos NM; Wang LX
Bioconjug Chem; 2006; 17(2):493-500. PubMed ID: 16536482
[TBL] [Abstract][Full Text] [Related]
35. Affinity of HIV-1 antibody 2G12 with monosaccharides: a theoretical study based on explicit and implicit water models.
Koyama Y; Ueno-Noto K; Takano K
Comput Biol Chem; 2014 Apr; 49():36-44. PubMed ID: 24583603
[TBL] [Abstract][Full Text] [Related]
36. [Localization of the HIV-1 gp120 conformational epitope recognized by virus neutralizing monoclonal antibodies 2G12].
Tumanova OIu; Kuvshinov VN; Il'ichev AA; Nekrasov BG; Ivanisenko VA; Kozlov AP; Sandakhchiev LS
Mol Biol (Mosk); 2002; 36(4):657-63. PubMed ID: 12173470
[TBL] [Abstract][Full Text] [Related]
37. Design and synthesis of a template-assembled oligomannose cluster as an epitope mimic for human HIV-neutralizing antibody 2G12.
Li H; Wang LX
Org Biomol Chem; 2004 Feb; 2(4):483-8. PubMed ID: 14770226
[TBL] [Abstract][Full Text] [Related]
38. Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A.
Witvrouw M; Fikkert V; Hantson A; Pannecouque C; O'keefe BR; McMahon J; Stamatatos L; de Clercq E; Bolmstedt A
J Virol; 2005 Jun; 79(12):7777-84. PubMed ID: 15919930
[TBL] [Abstract][Full Text] [Related]
39. The barley lectin, horcolin, binds high-mannose glycans in a multivalent fashion, enabling high-affinity, specific inhibition of cellular HIV infection.
Jayaprakash NG; Singh A; Vivek R; Yadav S; Pathak S; Trivedi J; Jayaraman N; Nandi D; Mitra D; Surolia A
J Biol Chem; 2020 Aug; 295(34):12111-12129. PubMed ID: 32636304
[No Abstract] [Full Text] [Related]
40. The neutral N-linked glycans of the ustilaginomycete yeast Sympodiomycopsis paphiopedili.
Flores RJD; Ohashi T; Kawasaki H; Fujiyama K
Yeast; 2017 Jul; 34(7):305-317. PubMed ID: 28384382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
